Back to top
loading...

AWS 12/11: November CPI +0.3%, Core +0.2%

+0.3% is the new headline number, up 10 basis points from the +0.2% expected but down from October's +0.4%.

+0.3% is the new headline number, up 10 basis points ...

Why Biotech ETFs Are Surging to New Highs

We have seen very strong M&A activity in the biotech space of late and the trend is expected to continue as big pharma companies try to gain an edge in the increasingly competitive cancer treatment market.

We have seen very strong M&A activity ...

Golden Globe Nominations: Who Gets the Biggest Boost?

Apple TV+ is expected to become a $9-billion-per-year business with 136 million paid subscribers by 2025, assuming that one in every 10 Apple users will pay for the service.

Apple TV+ is expected to become a $9-billion-per-year ...

›
‹

Investment Ideas

Stocks

ETFs

Mutual Funds

Options

Earnings Analysis

More Analysis
Sheraz Mian

Previewing the Q4 2019 Earnings Season

Earnings Preview

by

The December-quarter reporting season will not take the spotlight till we get into the New Year and the big banks start reporting results in mid-January. But the reporting season will actually get underway this week...

Earnings Headlines

View All

Reported Earnings Surprises

View All
Symbol Time Expected Reported %Surprise
VRA 08:11 0.19 0.20 +5.26
PLCE 07:12 3.02 3.03 +0.33
AEO 08:03 0.48 0.48 +0.00
PLAB 06:08 0.15 0.15 +0.00

EPS Positive Surprises for Dec 11, 2019

Symbol Time Expected Reported %Surprise
UNFI 07:21 0.23 0.12 -47.83

EPS Negative Surprises for Dec 11, 2019

Upcoming Earnings ESP

View More
Symbol ESP Most Accurate Estimate Consensus Estimate
LULU 1.28% 0.95 0.93
ADBE 0.12% 2.26 2.26
HEXO 6.98% -0.08 -0.09

Video Commentaries

Tesla: The Year It Finally Meets Management Goals

Tesla: The Year It Finally Meets Management Goals

This year may be the first year that the company finally meets their lofty goals. Tesla: https://www.zacks.com/stock/quote/TSLA?cid=CS-YOUTUBE-FT-VID Follow us on StockTwits: https://stocktwits.com/ZacksResearch Follow us on Twitter: https://twitter.com/ZacksResearch Like us on Facebook: https://www.facebook.com/ZacksInvestmentResearch

This year may be the first year that ...

Impeachment, USMCA, China Trade & Buy This Cheap Retail Stock – Free Lunch

Impeachment, USMCA, China Trade & Buy This Cheap Retail Stock – Free Lunch

On today’s episode of Free Lunch here at Zacks, Associate Stock Strategist Ben Rains discusses the latest news out of Washington that includes articles of impeachment against President Trump, House Democrats support for the new trade deal between the U.S., Mexico, and Canada, and what’s next on the U.S.-China trade war front. The episode also dives into some quarterly earnings results, before it closes with why Tilly\'s (TLYS) is a Zacks Rank #1 (Strong Buy) stock right now.

On today’s episode of Free Lunch here ...

Why Biotech ETFs are Rising

Why Biotech ETFs are Rising

Increasing M&A deals and cutting edge therapies are driving biotech ETFs higher. IShares Nasdaq Biotechnology ETF: https://www.zacks.com/funds/etf/IBB/profile?cid=CS-YOUTUBE-FT-VID SPDR S&P Biotech ETF: https://www.zacks.com/funds/etf/XBI/profile?cid=CS-YOUTUBE-FT-VID ARK Genomic Revolution ETF: https://www.zacks.com/funds/etf/ARKG/profile?cid=CS-YOUTUBE-FT-VID Virtus LifeSci Biotech Clinical Trials ETF: https://www.zacks.com/funds/etf/BBC/profile?cid=CS-YOUTUBE-FT-VID ALPS Medical Breakthroughs ETF: https://www.zacks.com/funds/etf/SBIO/profile?cid=CS-YOUTUBE-FT-VID Merck: https://www.zacks.com/stock/quote/MRK?cid=CS-YOUTUBE-FT-VID Biogen: https://www.zacks.com/stock/quote/BIIB?cid=CS-YOUTUBE-FT-VID Sanofi: https://www.zacks.com/stock/quote/SNY?cid=CS-YOUTUBE-FT-VID ArQule: https://www.zacks.com/stock/quote/ARQL?cid=CS-YOUTUBE-FT-VID Synthorx: https://www.zacks.com/stock/quote/THOR?cid=CS-YOUTUBE-FT-VID Follow us on StockTwits: https://stocktwits.com/ZacksResearch Follow us on Twitter: https://twitter.com/ZacksResearch Like us on Facebook: https://www.facebook.com/ZacksInvestmentResearch

Increasing M&A deals and cutting edge therapies ...

Zacks Partner Headlines

thestreet

marketwatch

cnn